Concentra Group Holdings Proxy Statement Filed
Ticker: CON · Form: DEF 14A · Filed: Mar 18, 2025 · CIK: 2014596
Sentiment: neutral
Topics: proxy-statement, annual-meeting, sec-filing
TL;DR
Concentra Group Holdings filed its proxy statement for the May 1st meeting. Shareholders get the details on what's being voted on.
AI Summary
Concentra Group Holdings Parent, Inc. filed its definitive proxy statement on March 18, 2025, for its annual meeting on May 1, 2025. The filing, under the 1934 Securities Exchange Act, provides information to shareholders regarding company matters to be voted on. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda for the upcoming annual meeting, including any proposals or director elections, allowing them to make informed voting decisions.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) providing information to shareholders, not indicating any immediate financial distress or significant operational change.
Key Numbers
- 1934 Act — SEC Act (Governing legislation for the filing)
Key Players & Entities
- Concentra Group Holdings Parent, Inc. (company) — Registrant
- Select Medical Corporation (company) — Associated company for business and mail address
- 0001104659-25-024771 (filing_id) — Accession Number
- 20250318 (date) — Filing Date
- 20250501 (date) — Meeting Date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a definitive proxy statement, is required by the SEC when a company is soliciting shareholder votes for its annual meeting or other matters. It provides detailed information about the company's operations, executive compensation, director nominees, and any proposals to be voted on.
When was the Concentra Group Holdings Parent, Inc. definitive proxy statement filed?
The definitive proxy statement for Concentra Group Holdings Parent, Inc. was filed on March 18, 2025.
What is the date of the meeting for which this proxy statement is being issued?
The proxy statement is for the annual meeting scheduled to be held on May 1, 2025.
What is the business address listed for Concentra Group Holdings Parent, Inc.?
The business address is C/O Select Medical Corporation, 5080 Spectrum Drive, Suite 1200W, Addison, TX 75001.
Under which SEC Act is this filing made?
This filing is made under the Securities Exchange Act of 1934.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 18, 2025 regarding Concentra Group Holdings Parent, Inc. (CON).